NNC 05-2090 hydrochloride

Name: NNC 05-2090 hydrochloride
Brand: MedChemExpress
SKU: HY-103509
Rating: 4.5 (1 reviews)

Cat. No.: HY-103509 Purity: 99.09%: FAQs
Data Sheet SDS COA Handling Instructions

Molarity Calculator

NNC 05-2090 hydrochloride is a GABA uptake inhibitor and inhibitor of the β-GABA transporter (BGT-1) (IC_{50< /sub>}: 10.6 μM). NNC 05-2090 hydrochloride also inhibits mGAT2 with a K_i value of 1.4 μM. NNC 05-2090 has anticonvulsant activity and can be used in the study of epilepsy and neurological diseases.

For research use only. We do not sell to patients.

NNC 05-2090 hydrochloride Chemical Structure

CAS No. : 184845-18-9

Size	Price	Stock	Quantity
5 mg	USD 130	In-stock	Estimated Time of Arrival: December 31
10 mg	USD 210	In-stock	Estimated Time of Arrival: December 31
50 mg	USD 840	In-stock	Estimated Time of Arrival: December 31
100 mg	USD 1480	In-stock	Estimated Time of Arrival: December 31
200 mg		Get quote
500 mg		Get quote

or Bulk Inquiry

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 1 publication(s) in Google Scholar

Other Forms of NNC 05-2090 hydrochloride:

NNC 05-2090 Get quote

Featured Recommendations

•Related Screening Libraries:

•Related Small Molecules:

•Related Proteins:

Biological Activity
Purity & Documentation
References
Customer Review

Description

In Vitro

NNC 05-2090 hydrochloride shows IC₅₀ values for binding with prazosin and spiperone of 266 and 1632 nM, respectively^[1].
NNC 05-2090 hydrochloride (0.1-100 μM) inhibits [³H]GABA uptake in synaptosomes from rat cortex with an IC₅₀ value of 4.4 μM^[1].
NNC 05-2090 hydrochloride (0.1-100 μM) inhibits [³H]GABA uptake in synaptosomes prepared from inferior colliculus with an IC₅₀ value of 2.5 μM^[1].
NNC 05-2090 hydrochloride inhibits serotonin, noradrenaline, dopamine transporters and BGT-1 with IC₅₀ values of 5.29, 7.91, 4.08 and 10.6 μM, respectively^[1].
NNC 05-2090 hydrochloride inhibits GAT-1, GAT-2 and GAT-3 with IC₅₀ values of 29.62, 45.29 and 22.51 μM, respectively^[1].
NNC 05-2090 dose-dependently inhibited sound-induced tonic and clonic convulsions in DBA/2 mice with an ED₅₀ value 19 μmol/kg^[2].
NNC 05-2090 dose-dependently antagonized tonic hindlimb extension in the maximal electroshock (MES) test with an ED₅₀ values of 73 mmol/kg^[2].
NNC 05-2090 significantly (PB0.05) reduces generalized seizure severity (seizure grade 3-5) at highest doses (72-242 mmol/kg) and NNC 05-2090 also significantly reduced afterdischarge duration at these doses (P<0.05)^[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

In Vivo

NNC 05-2090 hydrochloride (intraperitoneal injection) dose-dependently protects against maximal electroshock (MES) in mice with an ED₅₀ values of 73 μmol/kg, and shows ED₅₀ values against tonic and clonic convulsions in DBA/2 mice of 19 and 26 μmol /kg, respectively^[1].
NNC 05-2090 hydrochloride (0.01, 0.1 and 0.3 mg/kg; i.p. or i.,t., once) reverses mechanical allodynia in (partial sciatic nerve ligation) PSL model mice^[3].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:	Partial sciatic nerve ligation (PSL) mice with mechanical allodynia^[2]
Dosage:	0.01, 0.1 and 0.3 mg/kg
Administration:	Intraperitoneal injection or intrathecal injection; 0.1 mg/kg, once
Result:	Dose-dependently reversed mechanical allodynia in PSL model mice by both intraperitoneal injection and intrathecal injection.

Molecular Weight

451.00

Formula

C₂₇H₃₁ClN₂O₂

CAS No.

184845-18-9

Appearance

Solid

Color

Light yellow to yellow

SMILES

OC1(CCN(CC1)CCCN2C3=C(C4=C2C=CC=C4)C=CC=C3)C5=C(OC)C=CC=C5.Cl

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

4°C, sealed storage, away from moisture

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

Solvent & Solubility

In Vitro:

DMSO : 100 mg/mL (221.73 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

Preparing
Stock Solutions

Concentration Solvent Mass	1 mg	5 mg	10 mg

1 mM	2.2173 mL	11.0865 mL	22.1729 mL
5 mM	0.4435 mL	2.2173 mL	4.4346 mL
10 mM	0.2217 mL	1.1086 mL	2.2173 mL

View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Molarity Calculator
Dilution Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

This equation is commonly abbreviated as: C₁V₁ = C₂V₂

Concentration _(start)

Volume _(start)

Concentration _(final)

Volume _(final)

In Vivo:

Select the appropriate dissolution method based on your experimental animal and administration route.

For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

Protocol 1

Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: ≥ 2.5 mg/mL (5.54 mM); Clear solution

This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
Protocol 2

Add each solvent one by one: 10% DMSO 90% Corn Oil
Solubility: ≥ 2.5 mg/mL (5.54 mM); Clear solution

This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown). If the continuous dosing period exceeds half a month, please choose this protocol carefully.
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL Corn oil, and mix evenly.

In Vivo Dissolution Calculator

Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.

Please enter your animal formula composition:

DMSO +

Tween-80 +

Saline

Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.

The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).

Calculation results:

Working solution concentration: mg/mL

Method for preparing stock solution: mg drug dissolved in μL DMSO (Stock solution concentration: mg/mL).

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).

Method for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline.

If the continuous dosing period exceeds half a month, please choose this protocol carefully.

Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.

Purity & Documentation

Purity: 99.09%

Select Batch:

Data Sheet (279 KB) SDS (251 KB)

COA (254 KB) HNMR (233 KB) LCMS (93 KB)

Handling Instructions (2659 KB)

References

[1]. Dalby NO, et al. Anticonvulsant properties of two GABA uptake inhibitors NNC 05-2045 and NNC 05-2090, not acting preferentially on GAT-1. Epilepsy Res. 1997 Jul;28(1):51-61. [Content Brief]

[2]. Jinzenji A, et al. Antiallodynic action of 1-(3-(9H-Carbazol-9-yl)-1-propyl)-4-(2-methyoxyphenyl)-4-piperidinol (NNC05-2090), a betaine/GABA transporter inhibitor. J Pharmacol Sci. 2014;125(2):217-26. [Content Brief]

Complete Stock Solution Preparation Table

Optional Solvent	Concentration Solvent Mass	1 mg	5 mg	10 mg	25 mg

DMSO	1 mM	2.2173 mL	11.0865 mL	22.1729 mL	55.4324 mL
	5 mM	0.4435 mL	2.2173 mL	4.4346 mL	11.0865 mL
	10 mM	0.2217 mL	1.1086 mL	2.2173 mL	5.5432 mL
	15 mM	0.1478 mL	0.7391 mL	1.4782 mL	3.6955 mL
	20 mM	0.1109 mL	0.5543 mL	1.1086 mL	2.7716 mL
	25 mM	0.0887 mL	0.4435 mL	0.8869 mL	2.2173 mL
	30 mM	0.0739 mL	0.3695 mL	0.7391 mL	1.8477 mL
	40 mM	0.0554 mL	0.2772 mL	0.5543 mL	1.3858 mL
	50 mM	0.0443 mL	0.2217 mL	0.4435 mL	1.1086 mL
	60 mM	0.0370 mL	0.1848 mL	0.3695 mL	0.9239 mL
	80 mM	0.0277 mL	0.1386 mL	0.2772 mL	0.6929 mL
	100 mM	0.0222 mL	0.1109 mL	0.2217 mL	0.5543 mL